A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Coherent Biopharma (Hefei) Co., Ltd.
University Hospital, Brest
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Kalbe International Pte. Ltd
The First Affiliated Hospital of Dalian Medical University
European Institute of Oncology
Institut Paoli-Calmettes
Assistance Publique Hopitaux De Marseille
University Hospital, Antwerp
Chung Shan Medical University
Taoyuan General Hospital
Sichuan Cancer Hospital and Research Institute
National Taipei University of Nursing and Health Sciences
Hacettepe University
Central TB Research Institute
The First Affiliated Hospital of Guangzhou Medical University
Azienda Sanitaria-Universitaria Integrata di Udine
University of Turin, Italy
University Hospital, Essen
Hummingbird Diagnostics
Sichuan University
The University of Hong Kong
Peking Union Medical College Hospital
McMaster University
University Hospital, Ghent
Hunan Province Tumor Hospital
Global Healthy Living Foundation
Aalborg University Hospital
The University of Queensland
Vanderbilt-Ingram Cancer Center
Sanguine Biosciences
Sentara Cardiovascular Research Institute
Shanghai Chest Hospital
Vestre Viken Hospital Trust
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
University of Manchester
Shanghai Pulmonary Hospital, Shanghai, China
University of California, Davis
University of Milano Bicocca
Lebanese University
Institut Català d'Oncologia
University of South Carolina
Fondazione IRCCS Policlinico San Matteo di Pavia
Hospices Civils de Lyon
Assiut University
Shanghai Chest Hospital
Chang Gung Memorial Hospital
Laibin People's Hospital
Avistone Biotechnology Co., Ltd.
The University of Hong Kong